{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Long+Term&page=9", "query": { "condition": "Long Term", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 3045, "total_pages": 305, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Long+Term&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Long+Term&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T16:42:29.267Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06174987", "title": "A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced Cancer", "Metastatic Cancer" ], "interventions": [ { "name": "T-DXd", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2024-01-05", "completion_date": "2028-01-17", "has_results": false, "last_update_posted_date": "2025-10-15", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 2, "location_summary": "Miami, Florida • Durham, North Carolina", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06174987" }, { "nct_id": "NCT00924664", "title": "Long Term Safety Study of Tanezumab in Chronic Low Back Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Low Back Pain" ], "interventions": [ { "name": "Tanezumab 20 mg", "type": "BIOLOGICAL" }, { "name": "Tanezumab 10 mg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 849, "start_date": "2009-08-20", "completion_date": "2011-06-22", "has_results": true, "last_update_posted_date": "2021-04-21", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 149, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Hueytown, Alabama + 99 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Anniston", "state": "Alabama" }, { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00924664" }, { "nct_id": "NCT02724228", "title": "A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Achondroplasia" ], "interventions": [ { "name": "BMN 111", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioMarin Pharmaceutical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 30, "start_date": "2016-01-26", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-03-13", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 6, "location_summary": "Oakland, California • Torrance, California • Chicago, Illinois + 3 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02724228" }, { "nct_id": "NCT00987467", "title": "Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atopic Keratoconjunctivitis" ], "interventions": [ { "name": "Cyclosporin 0.05% ophthalmic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2007-08", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2018-04-02", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00987467" }, { "nct_id": "NCT01572792", "title": "Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)", "type": "DRUG" }, { "name": "Aclidinium bromide", "type": "DRUG" }, { "name": "Formoterol Fumarate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 921, "start_date": "2012-04", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2017-04-21", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 179, "location_summary": "Anniston, Alabama • Athens, Alabama • Birmingham, Alabama + 146 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01572792" }, { "nct_id": "NCT06698796", "title": "A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dermatomyositis", "Polymyositis" ], "interventions": [ { "name": "Dazukibart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 211, "start_date": "2025-01-22", "completion_date": "2031-07-29", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 4, "location_summary": "Glendale, Arizona • Frisco, Texas • Houston, Texas + 1 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Frisco", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Beckley", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06698796" }, { "nct_id": "NCT01804686", "title": "A Long-term Extension Study of PCI-32765 (Ibrutinib)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma", "Mantle Cell Lymphoma", "Follicular Lymphoma", "Diffuse Large B-cell Lymphoma", "Waldenstrom Macroglobulinemia", "Chronic Graft Versus Host Disease" ], "interventions": [ { "name": "Ibrutinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 539, "start_date": "2013-09-09", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 32, "location_summary": "Duarte, California • La Jolla, California • Los Angeles, California + 27 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01804686" }, { "nct_id": "NCT00314769", "title": "Long-Term Improvement in Motor Learning by Transcranial Direct Current Stimulation", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Volunteers" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 196, "start_date": "2006-04-07", "completion_date": "2013-12-16", "has_results": false, "last_update_posted_date": "2019-12-16", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00314769" }, { "nct_id": "NCT00241722", "title": "Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bowel Dysfunction", "Constipation" ], "interventions": [ { "name": "Alvimopan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 805, "start_date": "2005-08-01", "completion_date": "2007-02-01", "has_results": false, "last_update_posted_date": "2017-08-30", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 143, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 120 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00241722" }, { "nct_id": "NCT01168856", "title": "An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [], "intervention_types": [], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 734, "start_date": "2010-09", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-03-11", "last_synced_at": "2026-10-15T16:42:29.267Z", "location_count": 34, "location_summary": "La Jolla, California • Long Beach, California • Sacramento, California + 28 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01168856" } ] }